Skip to content

Effectiveness of Acupuncture treatment on Atopic Dermatitis Symptoms

Effectiveness of Acupuncture treatment on Atopic Dermatitis Symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002796
Enrollment
36
Registered
2018-04-13
Start date
2018-03-06
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Others : Acupuncture treatment is based on the recommendations of the revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) 2010. Manual acupuncture
LI2 and GB41 for tenderness around ST25, diarrhoea, or constipation
TE3 and SI3 for fullness in the chest and hypochondrium
TE3 and TE6 for lower abdominal pain and tenderness on the chest center
SI3 and GB41 or SI2 and BL66 for lower abdominal pain, dry skin, or heat in the upper body and cold in the lower body
and LR3 and SP3 for pain in the hypogastric region with darkness of the sublingual collateral vessels. Acupuncture treatment will be performed using a Park Sham device to maintain participant blindnes
Dongbang Acupuncture Inc., Bundang, Seongnam, Korea) will be used for needle treatment. The acupuncture will be inserted up to 5 to 30 mm depending on the acupoints and will be remained for 15 minutes

Sponsors

Kyung Hee University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: *Participants who meet all of the following criteria will be included: A. Men and women aged 19 to 64 B. Patients with atopic dermatitis diagnosed according to Hanifin & Rajka criteria C. Patients who were between 30 points and 80 points on the 100mm Pruritus Visual Analog Scale (VAS) D. Objective SCORAD scores between 10 and 40 points E. Patients who have not taken prescribed medicines related to Atopic dermatitis for the past month F. Understanding the purpose of this study and agreeing to participate G. Patients who have not participated in other clinical studies for the past month

Exclusion criteria

Exclusion criteria: Participants who meet any of the following criteria will be excluded: A. Severely fluctuating Atopic Dermatitis symptoms B. patients who receive other treatments(e.g. oral steroids) that may affect Atopic dermatitis or that research doctor thought to be inappropriate C. Patients with secondary infection at lesions of atopic dermatitis D. Patients with severe mental illness symptoms E. Pregnant women or those with a pregnancy plan during the study period or those who are lactating. F. Patients with a medical history that the Korean medicine doctor considers to be inadequate.

Design outcomes

Primary

MeasureTime frame
Scoring Atopic Dermatitis(SCORAD) Index

Secondary

MeasureTime frame
Eczema Area Severity Index(EASI);Patient Oriented Eczema Measure(POEM);Dermatology Life Quality Index(DLQI);Abdominal examination using Pressure Pain Threshold algometer(PPT);Nepean Dyspepsia Index-Korean version(NDI-K);Adequate Relief of Functional dyspepsia pain and discomfort;Visual Analog Scale about Dyspepsia symptoms;Credibility Test;Blinding Test;Electroencephalogram(EEG)

Countries

Korea, Republic of

Contacts

Public ContactPark Junggun

Kyung Hee University Oriental Medical Center

junatrium@gmail.com+82-2-958-9180

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 23, 2026